The effect of the synergy between sterigmatocystin and a fungal metabolite on Bacillus subtilis.
D000348:Aflatoxins / Q000378:metabolism; D001233:Aspergillus nidulans; D001412:Bacillus subtilis / Q000187:drug effects* / Q000378:metabolism; D001426:Bacterial Proteins / Q000096:biosynthesis; D001692:Biological Transport / Q000187:drug effects; D004269:DNA, Bacterial / Q000096:biosynthesis; D004357:Drug Synergism; D005656:Fungal Proteins / Q000494:pharmacology*; D006023:Glycoproteins / Q000494:pharmacology*; D012329:RNA, Bacterial / Q000096:biosynthesis; D013241:Sterigmatocystin / Q000378:metabolism / Q000494:pharmacology*; D014966:Xanthenes / Q000494:pharmacology*
D000348:Aflatoxins; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D005656:Fungal Proteins; D006023:Glycoproteins; D012329:RNA, Bacterial; D014966:Xanthenes; D013241:Sterigmatocystin; C027955:aflatoxin G1